Your browser doesn't support javascript.
loading
Predictors of recurrence in pheochromocytoma.
Press, Danielle; Akyuz, Muhammet; Dural, Cem; Aliyev, Shamil; Monteiro, Rosebel; Mino, Jeff; Mitchell, Jamie; Hamrahian, Amir; Siperstein, Allan; Berber, Eren.
Afiliação
  • Press D; Departments of Endocrine Surgery and Endocrinology, Cleveland Clinic, Cleveland, OH.
  • Akyuz M; Departments of Endocrine Surgery and Endocrinology, Cleveland Clinic, Cleveland, OH.
  • Dural C; Departments of Endocrine Surgery and Endocrinology, Cleveland Clinic, Cleveland, OH.
  • Aliyev S; Departments of Endocrine Surgery and Endocrinology, Cleveland Clinic, Cleveland, OH.
  • Monteiro R; Departments of Endocrine Surgery and Endocrinology, Cleveland Clinic, Cleveland, OH.
  • Mino J; Departments of Endocrine Surgery and Endocrinology, Cleveland Clinic, Cleveland, OH.
  • Mitchell J; Departments of Endocrine Surgery and Endocrinology, Cleveland Clinic, Cleveland, OH.
  • Hamrahian A; Departments of Endocrine Surgery and Endocrinology, Cleveland Clinic, Cleveland, OH.
  • Siperstein A; Departments of Endocrine Surgery and Endocrinology, Cleveland Clinic, Cleveland, OH.
  • Berber E; Departments of Endocrine Surgery and Endocrinology, Cleveland Clinic, Cleveland, OH. Electronic address: berbere@ccf.org.
Surgery ; 156(6): 1523-7; discussion 1527-8, 2014 Dec.
Article em En | MEDLINE | ID: mdl-25456947
ABSTRACT

BACKGROUND:

The recurrence rate of pheochromocytoma after adrenalectomy is 6.5-16.5%. This study aims to identify predictors of recurrence and optimal biochemical testing and imaging for detecting the recurrence of pheochromocytoma.

METHODS:

In this retrospective study we reviewed all patients who underwent adrenalectomy for pheochromocytoma during a 14-year period at a single institution.

RESULTS:

One hundred thirty-five patients had adrenalectomy for pheochromocytoma. Eight patients (6%) developed recurrent disease. The median time from initial operation to diagnosis of recurrence was 35 months. On multivariate analysis, tumor size >5 cm was an independent predictor of recurrence. One patient with recurrence died, 4 had stable disease, 2 had progression of disease, and 1 was cured. Recurrence was diagnosed by increases in plasma and/or urinary metanephrines and positive imaging in 6 patients (75%), and by positive imaging and normal biochemical levels in 2 patients (25%).

CONCLUSION:

Patients with large tumors (>5 cm) should be followed vigilantly for recurrence. Because 25% of patients with recurrence had normal biochemical levels, we recommend routine imaging and testing of plasma or urinary metanephrines for prompt diagnosis of recurrence.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Feocromocitoma / Neoplasias das Glândulas Suprarrenais / Adrenalectomia / Recidiva Local de Neoplasia Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Feocromocitoma / Neoplasias das Glândulas Suprarrenais / Adrenalectomia / Recidiva Local de Neoplasia Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article